[Federal Register Volume 66, Number 86 (Thursday, May 3, 2001)]
[Notices]
[Page 22240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-11157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Anesthetic and Life Support Drugs Advisory Committee; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces a forthcoming meeting of a public 
advisory committee of the Food and Drug Administration (FDA). The 
meeting will be open to the public.

    Name of Committee: Anesthetic and Life Support Drugs Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on June 14 and 15, 2001, 
8 a.m. to 5 p.m.
    Location: Holiday Inn, The Ballroom, Two Montgomery Village 
Ave., Gaithersburg, MD.
    Contact: Kimberly Topper, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, 
Rockville MD 20857, 301-827-7001, e-mail: <a href="/cdn-cgi/l/email-protection#b9cdd6c9c9dccbd2f9dadddccb97dfddd897ded6cf"><span class="__cf_email__" data-cfemail="790d1609091c0b12391a1d1c0b571f1d18571e160f">[email protected]</span></a>, FAX 
301-827-6801, or FDA Advisory Committee Information Line, 1-800-741-
8138 (301-443-0572 in the Washington, DC area), code 12529. Please 
call the Information Line for up-to-date information on this 
meeting.
    Agenda: On both days the committee will discuss the medical use 
of opiate analgesics in various patient populations, including 
pediatric patients and patients with chronic pain of nonmalignant 
etiology, as well as the risk to benefit ratio of extending opiate 
treatment into these populations. It will also address concerns 
regarding the abuse potential, diversion and increasing incidence of 
addiction to opiate analgesics, especially to the modified release 
opiate analgesics.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by June 7, 
2001. Oral presentation from the public will be scheduled between 
approximately 1 p.m. and 2 p.m each day. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before June 7, 2001, 
and submit a brief statement of the general nature of the evidence 
or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Background material from FDA will be posted 24 hours before the 
meeting at the Anesthetic and Life Support Drugs Advisory Committee 
docket site at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. 
(Click on the year 2001 and scroll down to Anesthetic and Life 
Support Drugs meetings.) This is the same Web site where you can 
find the minutes, transcript, and slides from the meeting. This 
material is generally posted about 3 weeks after the meeting.

    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 27, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-11157 Filed 4-30-01; 4:16 pm]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>